4 sources·Health

New Antibiotic Gepotidacin Shows Promise Against Gonorrhoea

Gepotidacin, a new antibiotic, effectively treats gonorrhoea, including drug-resistant strains, marking a significant advancement in STI treatment.

The distribution of story sources: left-leaning (blue), center (light gray), and right-leaning (red).
Reliable
The underlying sources consistently report facts with minimal bias, demonstrating high-quality journalism and accuracy.
Balanced
The underlying sources are either a balanced mix of left and right or primarily centrist.
Subscribe to unlock this story

We really don't like cutting you off, but you've reached your monthly limit. At just $5/month, subscriptions are how we keep this project going. Start your free 7-day trial today!

Get Started
  1. Potential new antibiotic for treating gonorrhoea

    The work was funded by pharmaceutical company GSK which makes the new tablets.

    Potential new antibiotic for treating gonorrhoea

    BBC NewsBBC News·19d
    Reliable
    This source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.
    ·
    Center
    This outlet is balanced or reflects centrist views.
  1. NBC News
  2. BBC News
  3. CNN
  4. The Guardian

Updated: Apr 14th, 2025, 11:32 AM ET

Summary

A summary of the key points of this story verified across multiple sources.

Gepotidacin, a novel antibiotic developed by GSK, demonstrated effectiveness in treating gonorrhoea in a recent study. With rising cases globally, including drug-resistant strains, it is seen as a potential breakthrough. In a clinical trial comparing gepotidacin with standard treatments, it was as effective at curing the infection. Some mild side effects were noted, but its oral form could enhance patient compliance compared to traditional injections. Experts highlight the need for continued development of new treatments as drug resistance grows, with potential implications for public health.


Perspectives

Compare opinions on this story from liberal (Left), conservative (Right) or center-leaning news organizations.
  • Gepotidacin shows promising effectiveness against gonorrhea and drug-resistant strains, representing a significant advancement in treatment options.

  • The drug works by targeting two key enzymes involved in bacterial replication, offering a novel mechanism compared to existing antibiotics.

  • With rising gonorrhea cases and increasing resistance to current treatments, the introduction of gepotidacin could play a crucial role in addressing public health concerns surrounding STIs.


FAQs

A list of follow-up questions readers often ask about this story.
New Antibiotic Gepotidacin Shows Promise Against Gonorrhoea - Pano News